These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26222195)

  • 1. A Ligand-Based Drug Design. Discovery of 4-Trifluoromethyl-7,8-pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2.
    Liu J; Pham PT; Skripnikova EV; Zheng S; Lovings LJ; Wang Y; Goyal N; Bellow SM; Mensah LM; Chatters AJ; Bratton MR; Wiese TE; Zhao M; Wang G; Foroozesh M
    J Med Chem; 2015 Aug; 58(16):6481-93. PubMed ID: 26222195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives.
    Shimada T; Tanaka K; Takenaka S; Murayama N; Martin MV; Foroozesh MK; Yamazaki H; Guengerich FP; Komori M
    Chem Res Toxicol; 2010 Dec; 23(12):1921-35. PubMed ID: 21053930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyranoflavones: a group of small-molecule probes for exploring the active site cavities of cytochrome P450 enzymes 1A1, 1A2, and 1B1.
    Liu J; Taylor SF; Dupart PS; Arnold CL; Sridhar J; Jiang Q; Wang Y; Skripnikova EV; Zhao M; Foroozesh M
    J Med Chem; 2013 May; 56(10):4082-92. PubMed ID: 23600958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
    Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
    Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds.
    Shimada T; Murayama N; Tanaka K; Takenaka S; Guengerich FP; Yamazaki H; Komori M
    Chem Res Toxicol; 2011 Aug; 24(8):1327-37. PubMed ID: 21732699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1.
    Shimada T; Yamazaki H; Foroozesh M; Hopkins NE; Alworth WL; Guengerich FP
    Chem Res Toxicol; 1998 Sep; 11(9):1048-56. PubMed ID: 9760279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis.
    Chun YJ; Kim S; Kim D; Lee SK; Guengerich FP
    Cancer Res; 2001 Nov; 61(22):8164-70. PubMed ID: 11719446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 7-Ethynylcoumarins: selective inhibitors of human cytochrome P450s 1A1 and 1A2.
    Liu J; Nguyen TT; Dupart PS; Sridhar J; Zhang X; Zhu N; Stevens CL; Foroozesh M
    Chem Res Toxicol; 2012 May; 25(5):1047-57. PubMed ID: 22443586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol is a selective human cytochrome P450 1A1 inhibitor.
    Chun YJ; Kim MY; Guengerich FP
    Biochem Biophys Res Commun; 1999 Aug; 262(1):20-4. PubMed ID: 10448061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cytochrome p450 enzymes by quinones and anthraquinones.
    Sridhar J; Liu J; Foroozesh M; Klein Stevens CL
    Chem Res Toxicol; 2012 Feb; 25(2):357-65. PubMed ID: 22185593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human cytochrome P450 enzymes by 1,2-dithiole-3-thione, oltipraz and its derivatives, and sulforaphane.
    Langouët S; Furge LL; Kerriguy N; Nakamura K; Guillouzo A; Guengerich FP
    Chem Res Toxicol; 2000 Apr; 13(4):245-52. PubMed ID: 10775323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane.
    Chun J; Kent UM; Moss RM; Sayre LM; Hollenberg PF
    Drug Metab Dispos; 2000 Aug; 28(8):905-11. PubMed ID: 10901699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LKY-047: First Selective Inhibitor of Cytochrome P450 2J2.
    Phuc NM; Wu Z; O Y; Lee JH; Oh S; Song GY; Liu KH
    Drug Metab Dispos; 2017 Jul; 45(7):765-769. PubMed ID: 28461575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of coumarin-based fluorogenic P450 BM3 substrates and prospects for competitive inhibition screenings.
    Neufeld K; Zu Berstenhorst SM; Pietruszka J
    Anal Biochem; 2014 Jul; 456():70-81. PubMed ID: 24708937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ortho-Methylarylamines as Time-Dependent Inhibitors of Cytochrome P450 1A1 Enzyme.
    Sridhar J; Liu J; Komati R; Schroeder R; Jiang Q; Tram P; Riley K; Foroozesh M
    Drug Metab Lett; 2017; 10(4):270-277. PubMed ID: 28000546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of flavone propargyl ethers as potent and selective inhibitors of cytochrome P450 enzymes 1A1 and 1A2.
    Sridhar J; Ellis J; Dupart P; Liu J; Stevens CL; Foroozesh M
    Drug Metab Lett; 2012; 6(4):275-84. PubMed ID: 23506553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of cytochrome P450 1A2-mediated formation of N-hydroxy arylamines and heterocyclic amines and their reaction with guanyl residues.
    Guengerich FP; Humphreys WG; Yun CH; Hammons GJ; Kadlubar FF; Seto Y; Okazaki O; Martin MV
    Princess Takamatsu Symp; 1995; 23():78-84. PubMed ID: 8844798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dibenzoylmethane modulates aryl hydrocarbon receptor function and expression of cytochromes P50 1A1, 1A2, and 1B1.
    MacDonald CJ; Ciolino HP; Yeh GC
    Cancer Res; 2001 May; 61(10):3919-24. PubMed ID: 11358806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 activation of arylamines and heterocyclic amines.
    Kim D; Guengerich FP
    Annu Rev Pharmacol Toxicol; 2005; 45():27-49. PubMed ID: 15822170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions among P450 enzymes when combined in reconstituted systems: formation of a 2B4-1A2 complex with a high affinity for NADPH-cytochrome P450 reductase.
    Backes WL; Batie CJ; Cawley GF
    Biochemistry; 1998 Sep; 37(37):12852-9. PubMed ID: 9737863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.